Aier Eye Hospital Group Co (300015) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2025 reached RMB 6.03 billion, up 15.97% year-over-year, with net profit attributable to shareholders rising 16.71% to RMB 1.05 billion.

• Operating cash flow increased 41.04% year-over-year to RMB 1.82 billion, reflecting robust business expansion.

• The company expanded its hospital network and saw growth in both revenue and costs due to increased scale.

Financial highlights

• Operating income: RMB 6.03 billion, up 15.97% year-over-year; net profit attributable to shareholders: RMB 1.05 billion, up 16.71%.

• Basic EPS: RMB 0.1136, up 16.39% year-over-year; diluted EPS: RMB 0.1136, up 16.87%.

• Operating cash flow: RMB 1.82 billion, up 41.04% year-over-year.

• Total assets at quarter-end: RMB 34.58 billion, up 4.00% from year-end 2024.

• Net assets attributable to shareholders: RMB 21.84 billion, up 5.43% from year-end 2024.

Key financial ratios and metrics

• Weighted average ROE: 4.93%, up 0.26 percentage points year-over-year.

• Gross margin and cost increases aligned with business expansion; operating costs rose 16.59% year-over-year.

• Adjusted net profit (excluding non-recurring items): RMB 1.06 billion, up 25.78% year-over-year.